Cargando…
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy
Purpose: To present data on clinical response to eplerenone over a 1-year period in patients with central serous chorioretinopathy (CSC), and to evaluate optical coherence tomography (OCT) variables as predictors of treatment response at 3- and 12-month follow-up visits. Methods: Patients with acute...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781176/ https://www.ncbi.nlm.nih.gov/pubmed/31443376 http://dx.doi.org/10.3390/jcm8091271 |
_version_ | 1783457309235609600 |
---|---|
author | Borrelli, Enrico Zuccaro, Biancamaria Zucchiatti, Ilaria Parravano, Mariacristina Querques, Lea Costanzo, Eliana Sacconi, Riccardo Prascina, Francesco Scarinci, Fabio Bandello, Francesco Querques, Giuseppe |
author_facet | Borrelli, Enrico Zuccaro, Biancamaria Zucchiatti, Ilaria Parravano, Mariacristina Querques, Lea Costanzo, Eliana Sacconi, Riccardo Prascina, Francesco Scarinci, Fabio Bandello, Francesco Querques, Giuseppe |
author_sort | Borrelli, Enrico |
collection | PubMed |
description | Purpose: To present data on clinical response to eplerenone over a 1-year period in patients with central serous chorioretinopathy (CSC), and to evaluate optical coherence tomography (OCT) variables as predictors of treatment response at 3- and 12-month follow-up visits. Methods: Patients with acute or chronic CSC treated with eplerenone were retrospectively included. Clinical and imaging characteristics were recorded at baseline and at the 3-month and 12-month follow-up visits. Changes from baseline in quantitative measurements were calculated at each follow-up. Logistic regression analysis was computed to correlate clinical and OCT parameters at baseline with response to treatment at 3 and 12 months of follow-up. Results: A total of 50 eyes of 50 patients were included in the study. Mean ± SD best corrected visual acuity (BCVA) was 0.20 ± 0.14 Logarithm of the Minimum Angle of Resolution (LogMAR) at baseline and significantly improved at both the 3-month (0.12 ± 0.13 LogMAR, p < 0.0001) and 12-month (0.10 ± 0.12 LogMAR, p < 0.0001) follow-up visits. At the 3-month follow-up visit, 25 out of 50 eyes (50.0%) demonstrated macular complete subretinal fluid (SRF) resolution, while 13 eyes (26.0%) showed macular partial SRF resolution, and 12 eyes (24%) had neither partial nor complete macular SRF resolution. Among those patients with macular partial or complete SRF resolution at 3 months and thus not shifted to photodynamic therapy, 36 out of 38 cases had macular complete SRF resolution at the 12-month follow-up visit. There was a significant change from baseline at both follow-up visits in all anatomical OCT parameters (except for reduction in choroidal thickness that did not reach the statistical significance at the 12-month follow-up visit). Several OCT parameters at baseline were independently significant predictors for macular subretinal fluid complete resolution at 3 months, including (i) a thicker subfoveal choroidal thickness; (ii) a smaller subretinal fluid maximum diameter; (iii) a lower number of serous pigment epithelium detachments; and (iv) a lower number of intraretinal hyperreflective foci. Conclusion: Treatment with eplerenone in CSC patients is confirmed to be beneficial for both anatomical and functional outcomes. We identified attractive OCT metrics that could potentially be used as a tool to select patients who might mainly benefit from this treatment. |
format | Online Article Text |
id | pubmed-6781176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67811762019-10-30 Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy Borrelli, Enrico Zuccaro, Biancamaria Zucchiatti, Ilaria Parravano, Mariacristina Querques, Lea Costanzo, Eliana Sacconi, Riccardo Prascina, Francesco Scarinci, Fabio Bandello, Francesco Querques, Giuseppe J Clin Med Article Purpose: To present data on clinical response to eplerenone over a 1-year period in patients with central serous chorioretinopathy (CSC), and to evaluate optical coherence tomography (OCT) variables as predictors of treatment response at 3- and 12-month follow-up visits. Methods: Patients with acute or chronic CSC treated with eplerenone were retrospectively included. Clinical and imaging characteristics were recorded at baseline and at the 3-month and 12-month follow-up visits. Changes from baseline in quantitative measurements were calculated at each follow-up. Logistic regression analysis was computed to correlate clinical and OCT parameters at baseline with response to treatment at 3 and 12 months of follow-up. Results: A total of 50 eyes of 50 patients were included in the study. Mean ± SD best corrected visual acuity (BCVA) was 0.20 ± 0.14 Logarithm of the Minimum Angle of Resolution (LogMAR) at baseline and significantly improved at both the 3-month (0.12 ± 0.13 LogMAR, p < 0.0001) and 12-month (0.10 ± 0.12 LogMAR, p < 0.0001) follow-up visits. At the 3-month follow-up visit, 25 out of 50 eyes (50.0%) demonstrated macular complete subretinal fluid (SRF) resolution, while 13 eyes (26.0%) showed macular partial SRF resolution, and 12 eyes (24%) had neither partial nor complete macular SRF resolution. Among those patients with macular partial or complete SRF resolution at 3 months and thus not shifted to photodynamic therapy, 36 out of 38 cases had macular complete SRF resolution at the 12-month follow-up visit. There was a significant change from baseline at both follow-up visits in all anatomical OCT parameters (except for reduction in choroidal thickness that did not reach the statistical significance at the 12-month follow-up visit). Several OCT parameters at baseline were independently significant predictors for macular subretinal fluid complete resolution at 3 months, including (i) a thicker subfoveal choroidal thickness; (ii) a smaller subretinal fluid maximum diameter; (iii) a lower number of serous pigment epithelium detachments; and (iv) a lower number of intraretinal hyperreflective foci. Conclusion: Treatment with eplerenone in CSC patients is confirmed to be beneficial for both anatomical and functional outcomes. We identified attractive OCT metrics that could potentially be used as a tool to select patients who might mainly benefit from this treatment. MDPI 2019-08-22 /pmc/articles/PMC6781176/ /pubmed/31443376 http://dx.doi.org/10.3390/jcm8091271 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Borrelli, Enrico Zuccaro, Biancamaria Zucchiatti, Ilaria Parravano, Mariacristina Querques, Lea Costanzo, Eliana Sacconi, Riccardo Prascina, Francesco Scarinci, Fabio Bandello, Francesco Querques, Giuseppe Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title | Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title_full | Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title_fullStr | Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title_full_unstemmed | Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title_short | Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy |
title_sort | optical coherence tomography parameters as predictors of treatment response to eplerenone in central serous chorioretinopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781176/ https://www.ncbi.nlm.nih.gov/pubmed/31443376 http://dx.doi.org/10.3390/jcm8091271 |
work_keys_str_mv | AT borrellienrico opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT zuccarobiancamaria opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT zucchiattiilaria opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT parravanomariacristina opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT querqueslea opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT costanzoeliana opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT sacconiriccardo opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT prascinafrancesco opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT scarincifabio opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT bandellofrancesco opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy AT querquesgiuseppe opticalcoherencetomographyparametersaspredictorsoftreatmentresponsetoeplerenoneincentralserouschorioretinopathy |